Director · Pelthos Therapeutics Inc. · Common Stock
Side
SELL
Value
$18K
Shares
692
Price
$26
Executed
Jul 2, 2026
Disclosed
Jul 7, 2026
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Jul 2 executedJul 7, 2026 disclosed
PTHS · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Pauls Matthew filed this Form 4 reporting a open-market sale of PTHS on Jul 2, 2026. It became public on Jul 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Pauls Matthewcik:0001573429
Issuer
Pelthos Therapeutics Inc.cik:0001919246
Revision history · 0
No field has changed since this record was first ingested.
